| Bioclate (Armour), Recombinate |
103375 |
004 |
351(a) |
Antihemophilic Factor (Recombinant) |
For Injection |
Intravenous |
1500IU |
Single-Dose Vial |
2010/03/10
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Bioclate (Armour), Recombinate |
103375 |
005 |
351(a) |
Antihemophilic Factor (Recombinant) |
For Injection |
Intravenous |
2000IU |
Single-Dose Vial |
2010/03/10
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
|
N/A |
| Hizentra |
125350 |
001 |
351(a) |
Immune Globulin Subcutaneous (Human), 20% Liquid |
Injection |
Subcutaneous |
2G/10ML |
Single-Dose Vial |
2010/03/04
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |
| Hizentra |
125350 |
002 |
351(a) |
Immune Globulin Subcutaneous (Human), 20% Liquid |
Injection |
Subcutaneous |
1G/5ML |
Single-Dose Vial |
2010/03/04
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |
| Hizentra |
125350 |
003 |
351(a) |
Immune Globulin Subcutaneous (Human), 20% Liquid |
Injection |
Subcutaneous |
10G/50ML |
Single-Dose Vial |
2010/03/04
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |
| Hizentra |
125350 |
004 |
351(a) |
Immune Globulin Subcutaneous (Human), 20% Liquid |
Injection |
Subcutaneous |
4G/20ML |
Single-Dose Vial |
2010/03/04
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |
| Norditropin |
021148 |
008 |
351(a) |
somatropin |
Injection |
Subcutaneous |
5MG/1.5ML |
Autoinjector |
2010/03/01
|
Novo Nordisk Inc. |
Rx |
Licensed |
N/A |
N/A |
| Norditropin |
021148 |
009 |
351(a) |
somatropin |
Injection |
Subcutaneous |
10MG/1.5ML |
Autoinjector |
2010/03/01
|
Novo Nordisk Inc. |
Rx |
Licensed |
N/A |
N/A |
| Norditropin |
021148 |
010 |
351(a) |
somatropin |
Injection |
Subcutaneous |
15MG/1.5ML |
Autoinjector |
2010/03/01
|
Novo Nordisk Inc. |
Rx |
Licensed |
N/A |
N/A |
| VPRIV |
022575 |
001 |
351(a) |
velaglucerase alfa |
For Injection |
Intravenous |
400UNITS |
Single-Dose Vial |
2010/02/26
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
N/A |
N/A |
| VPRIV |
022575 |
002 |
351(a) |
velaglucerase alfa |
For Injection |
Intravenous |
200UNITS |
Single-Dose Vial |
2010/02/26
|
Takeda Pharmaceuticals U.S.A., Inc. |
Disc |
Licensed |
N/A |
N/A |
| Prevnar 13 |
125324 |
001 |
351(a) |
Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) |
Injection |
Intramuscular |
0.5ML |
Pre-Filled Syringe |
2010/02/24
|
Wyeth Pharmaceuticals LLC |
Disc |
Licensed |
|
N/A |
| Menveo |
125300 |
001 |
351(a) |
Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine |
Injection |
Intramuscular |
0.5ML |
Single-Dose Vial |
2010/02/19
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
N/A |
| Xiaflex |
125338 |
001 |
351(a) |
collagenase clostridium histolyticum |
For Injection |
Intralesional |
0.9MG |
Single-Dose Vial |
2010/02/02
|
Auxilium Pharmaceuticals, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Actemra |
125276 |
001 |
351(a) |
tocilizumab |
Injection |
Intravenous |
80MG/4ML (20MG/ML)
|
Single-Dose Vial |
2010/01/08
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Actemra |
125276 |
002 |
351(a) |
tocilizumab |
Injection |
Intravenous |
200MG/10ML (20MG/ML) |
Single-Dose Vial |
2010/01/08
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Actemra |
125276 |
003 |
351(a) |
tocilizumab |
Injection |
Intravenous |
400MG/20ML (20MG/ML) |
Single-Dose Vial |
2010/01/08
|
Genentech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Stelara |
125261 |
003 |
351(a) |
ustekinumab |
Injection |
Subcutaneous |
45MG/0.5ML |
Pre-Filled Syringe |
2009/12/30
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Stelara |
125261 |
004 |
351(a) |
ustekinumab |
Injection |
Subcutaneous |
90MG/ML |
Pre-Filled Syringe |
2009/12/30
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent |
103914 |
003 |
351(a) |
Influenza Virus Vaccine |
Injection |
Intramuscular |
180 UG/.5ML |
Pre-Filled Syringe |
2009/12/23
|
Sanofi Pasteur Inc. |
Rx |
Licensed |
|
N/A |